.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
McKesson
Boehringer Ingelheim
US Army
Express Scripts
Farmers Insurance
Medtronic
Merck
Daiichi Sankyo
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

Epirubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for epirubicin hydrochloride and what is the scope of epirubicin hydrochloride freedom to operate?

Epirubicin hydrochloride
is the generic ingredient in two branded drugs marketed by Hospira, Fresenius Kabi Usa, Fresenius Kabi Oncol, Impax Labs Inc, Ebewe Pharma, Actavis Totowa, Cipla Ltd, Akorn Inc, Mustafa Nevsat, Mylan Institutional, Hisun Pharm Hangzhou, Pfizer Inc, West-ward Pharms Int, and Mylan Labs Ltd, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for epirubicin hydrochloride. Eleven suppliers are listed for this compound.

Summary for Generic Name: epirubicin hydrochloride

Tradenames:2
Patents:1
Applicants:14
NDAs:15
Drug Master File Entries: see list9
Suppliers / Packagers: see list11
Bulk Api Vendors: see list75
Clinical Trials: see list2,512
Patent Applications: see list6,743
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:epirubicin hydrochloride at DailyMed

Pharmacology for Ingredient: epirubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION065371-001Nov 28, 2007DISCNNoNo► Subscribe► Subscribe
Pfizer Inc
ELLENCE
epirubicin hydrochloride
INJECTABLE;INJECTION050778-001Sep 15, 1999APRXYesYes► Subscribe► Subscribe
Mustafa Nevsat
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION090266-001Apr 15, 2011DISCNNoNo► Subscribe► Subscribe
Ebewe Pharma
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION065339-001Dec 22, 2009DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
INJECTABLE;INJECTION065408-001Oct 15, 2007APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
McKesson
McKinsey
Federal Trade Commission
Chinese Patent Office
Boehringer Ingelheim
Julphar
Colorcon
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot